AMGEN INC filings

SEC filings by AMGEN INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13VANGUARD GROUP INCAMGEN INC49,036,3119.2%EDGAR
SC 13G/A2024-01-30STATE STREET CORPAMGEN INC-5.5%EDGAR
SC 13G/A2024-01-25BlackRock Inc.AMGEN INC47,811,3568.9%EDGAR
SC 13D2023-09-27AMGEN INCNeumora Therapeutics, Inc.35,368,65323.2%EDGAR
SC 13G/A2023-02-10AMGEN INCJasper Therapeutics, Inc.1,009,929-EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCAMGEN INC48,065,1399.0%EDGAR
SC 13G/A2023-02-07BlackRock Inc.AMGEN INC48,513,0799.1%EDGAR
SC 13G/A2023-02-06STATE STREET CORPAMGEN INC-5.6%EDGAR
SC 13G2022-12-02AMGEN INCNewAmsterdam Pharma Co N.V.4,910,000-EDGAR
SC 13G/A2022-02-11Capital Research Global InvestorsAMGEN INC22,157,9063.9%EDGAR
SC 13G/A2022-02-10STATE STREET CORPAMGEN INC-5.4%EDGAR
SC 13G/A2022-02-09VANGUARD GROUP INCAMGEN INC46,661,0098.3%EDGAR
SC 13G/A2022-02-01BlackRock Inc.AMGEN INC50,046,3458.9%EDGAR
SC 13G2022-01-12AMGEN INCVigil Neuroscience, Inc.3,206,281-EDGAR
SC 13G2021-10-01AMGEN INCJasper Therapeutics, Inc.2,700,000-EDGAR
SC 13G/A2021-02-16Capital Research Global InvestorsAMGEN INC31,762,3275.5%EDGAR
SC 13G/A2021-02-10VANGUARD GROUP INCAMGEN INC47,227,2298.1%EDGAR
SC 13G/A2021-02-05AMGEN INCProvention Bio, Inc.2,500,000-EDGAR
SC 13G/A2021-02-05AMGEN INCAkero Therapeutics, Inc.1,508,375-EDGAR
SC 13G2021-02-05STATE STREET CORPAMGEN INC-5.2%EDGAR